Axitinib combination therapies versus sunitinib for renal cell carcinoma

被引：0
|
作者：
Stirrups, Robert
机构：
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 03期
关键词：
D O I：
10.1016/S1470-2045(19)30104-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：E141 / E141
页数：1
相关论文
共 50 条
  • [21] Avelumab and axitinib combination therapy for the treatment of advanced renal cell carcinoma
    Soleimani, Maryam
    Nappi, Lucia
    Kollmannsberger, Christian
    FUTURE ONCOLOGY, 2020, 16 (36) : 3021 - 3034
  • [22] Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma
    Herrmann, E.
    Marschner, N.
    Grimm, M. O.
    Ohlmann, C. H.
    Hutzschenreuter, U.
    Overkamp, F.
    Groschek, M.
    Blumenstengel, K.
    Puehse, G.
    Steiner, T.
    WORLD JOURNAL OF UROLOGY, 2011, 29 (03) : 361 - 366
  • [23] An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy Failed
    Sherman, Steven
    Amzal, Billy
    Calvo, Emiliano
    Wang, Xufang
    Park, Jinhee
    Liu, Zhimei
    Lin, Chinjune
    Casciano, Roman
    CLINICAL THERAPEUTICS, 2015, 37 (11) : 2552 - 2559
  • [24] Cost-Effectivenessof Pembrolizumab plus Axitinib Versus Sunitinib asFirst-LineTherapy in Advanced Renal Cell Carcinoma in the US
    Ding, Dong
    Hu, Huabin
    Shi, Yin
    She, Longjiang
    Yao, Linli
    Zhu, Youwen
    Zeng, Shan
    Shen, Liangfang
    Huang, Jin
    ONCOLOGIST, 2021, 26 (02): : E290 - E297
  • [25] COST-EFFECTIVENESS OF PEMBROLIZUMAB/AXITINIB AND NIVOLUMAB/IPILIMUMAB VERSUS SUNITINIB AS TREATMENT FOR ADVANCED RENAL CELL CARCINOMA IN THE UNITED STATES
    Yu, J. C.
    Gong, C.
    Zahoor, H.
    Hay, J. W.
    VALUE IN HEALTH, 2020, 23 : S381 - S382
  • [26] Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma
    E. Herrmann
    N. Marschner
    M. O. Grimm
    C. H. Ohlmann
    U. Hutzschenreuter
    F. Overkamp
    M. Groschek
    K. Blumenstengel
    G. Pühse
    T. Steiner
    World Journal of Urology, 2011, 29 : 361 - 366
  • [27] Sunitinib and Axitinib increase secretion and glycolytic activity of small extracellular vesicles in renal cell carcinoma
    Lim, Aaron R.
    Vincent, Benjamin G.
    Weaver, Alissa M.
    Rathmell, W. Kimryn
    CANCER GENE THERAPY, 2022, 29 (06) : 683 - 696
  • [28] Sunitinib and Axitinib increase secretion and glycolytic activity of small extracellular vesicles in renal cell carcinoma
    Aaron R. Lim
    Benjamin G. Vincent
    Alissa M. Weaver
    W. Kimryn Rathmell
    Cancer Gene Therapy, 2022, 29 : 683 - 696
  • [29] Comparative efficacy of axitinib versus sorafenib for advanced renal cell carcinoma
    不详
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2012, 1 (01) : 11 - 12
  • [30] Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Cella, David
    Reeves, James
    Hawkins, Robert
    Guo, Jun
    Nathan, Paul
    Staehler, Michael
    de Souza, Paul
    Merchan, Jaime R.
    Boleti, Ekaterini
    Fife, Kate
    Jin, Jie
    Jones, Robert
    Uemura, Hirotsugu
    De Giorgi, Ugo
    Harmenberg, Ulrika
    Wang, Jinwan
    Sternberg, Cora N.
    Deen, Keith
    McCann, Lauren
    Hackshaw, Michelle D.
    Crescenzo, Rocco
    Pandite, Lini N.
    Choueiri, Toni K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08): : 722 - 731
12345